BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31884560)

  • 1. ASO Author Reflections: Emerging Risk Factors in Colon Cancer-End of the Line for Clinomics?
    Osterman E; Glimelius B
    Ann Surg Oncol; 2020 Apr; 27(4):1046-1047. PubMed ID: 31884560
    [No Abstract]   [Full Text] [Related]  

  • 2. Postoperative CEA and Other Non-traditional Risk Factors for Colon Cancer Recurrence: Findings from Swedish Population-Based Data.
    Kwaan MR
    Ann Surg Oncol; 2020 Apr; 27(4):971-972. PubMed ID: 31853758
    [No Abstract]   [Full Text] [Related]  

  • 3. High preoperative serum carcinoembryonic antigen predicts metastatic recurrence in potentially curative colonic cancer: results of a five-year study.
    Wiratkapun S; Kraemer M; Seow-Choen F; Ho YH; Eu KW
    Dis Colon Rectum; 2001 Feb; 44(2):231-5. PubMed ID: 11227940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative Serum Carcinoembryonic Antigen Level as a Prognostic Factor for Recurrence and Survival After Curative Resection Followed by Adjuvant Chemotherapy in Stage III Colon Cancer.
    Kim CG; Ahn JB; Jung M; Beom SH; Heo SJ; Kim JH; Kim YJ; Kim NK; Min BS; Koom WS; Kim H; Roh YH; Ma BG; Shin SJ
    Ann Surg Oncol; 2017 Jan; 24(1):227-235. PubMed ID: 27699609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic Permeation Predicts Systemic Recurrence in Combination with Vascular Involvement in Laparoscopically Resected N0 Colon Cancer.
    Kojo K; Katoh H; Naito M; Yamashita K; Nakamura T; Sato T; Yamanashi T; Watanabe M
    Am Surg; 2017 Dec; 83(12):1394-1400. PubMed ID: 29336761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
    Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T
    Oncology; 2017; 92(5):276-282. PubMed ID: 28178692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of Pretreatment Carcinoembryonic Antigen Level as a Prognostic Factor for Colon Cancer: Incorporating a C Stage in the AJCC TNM Classification.
    Amri R; Berger DL
    JAMA Surg; 2015 Aug; 150(8):755-6. PubMed ID: 26083189
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk Factors for Local Recurrence after Emergency Resection for Colon Cancer: Scenario in Sweden.
    Brännström F; Gunnarsson U
    Dig Surg; 2016; 33(6):503-8. PubMed ID: 27296713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of prostate specific antigen (PSA) and carcinoembryonic antigen (CEA) in screening for prostate and recurrent colon cancers in the elderly.
    Vandenberg TA
    Clin Biochem; 1993 Dec; 26(6):429-30. PubMed ID: 7510220
    [No Abstract]   [Full Text] [Related]  

  • 10. Left colon as a novel high-risk factor for postoperative recurrence of stage II colon cancer.
    Wang L; Hirano Y; Ishii T; Kondo H; Hara K; Obara N; Yamaguchi S
    World J Surg Oncol; 2020 Mar; 18(1):54. PubMed ID: 32160919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEA for monitoring colon cancer.
    Chu DZ; Ellenhorn JD; Paz IB; Wagman LD; Williams WL
    JAMA; 1994 Feb; 271(5):345-6; author reply 346-7. PubMed ID: 8283579
    [No Abstract]   [Full Text] [Related]  

  • 12. Caution is required before recommending routine carcinoembryonic antigen and imaging follow-up for patients with early-stage colon cancer.
    Chao M; Gibbs P
    J Clin Oncol; 2009 Dec; 27(36):e279-80; author reply e281. PubMed ID: 19901127
    [No Abstract]   [Full Text] [Related]  

  • 13. CEA for monitoring colon cancer.
    Cohen AM; Paty P
    JAMA; 1994 Feb; 271(5):346; author reply 346-7. PubMed ID: 8283580
    [No Abstract]   [Full Text] [Related]  

  • 14. The usefulness of carcinoembryonic antigen in postoperative colorectal cancer patients.
    Nelson RL
    Dis Colon Rectum; 1997 Jul; 40(7):866-7. PubMed ID: 9221868
    [No Abstract]   [Full Text] [Related]  

  • 15. CEA for monitoring colon cancer.
    Corman M; Prager ED
    JAMA; 1994 Feb; 271(5):346; author reply 346-7. PubMed ID: 8283581
    [No Abstract]   [Full Text] [Related]  

  • 16. Dukes C2 colon cancer: what is appropriate follow-up?
    Semin Oncol; 1995 Jun; 22(3):xix; discussion xix-xx passim. PubMed ID: 7777864
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: Patterns of Metastases in Patients with Obstructing Colorectal Cancer.
    Boeding JRE; Schreinemakers JMJ
    Ann Surg Oncol; 2020 Apr; 27(4):1056-1057. PubMed ID: 32048091
    [No Abstract]   [Full Text] [Related]  

  • 18. Carcinoembryonic antigen in prognosis of colorectal cancer.
    N Engl J Med; 1978 Dec; 299(24):1369-70. PubMed ID: 714113
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival.
    Thirunavukarasu P; Talati C; Munjal S; Attwood K; Edge SB; Francescutti V
    JAMA Surg; 2015 Aug; 150(8):747-755. PubMed ID: 26083632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inadequate quality of surveillance after curative surgery for colon cancer.
    Viehl CT; Ochsner A; von Holzen U; Cecini R; Langer I; Guller U; Laffer U; Oertli D; Zuber M
    Ann Surg Oncol; 2010 Oct; 17(10):2663-9. PubMed ID: 20429036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.